ERIS Lifescience

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE406M01024
  • NSEID: ERIS
  • BSEID: 540596
INR
1,380.00
-9.45 (-0.68%)
BSENSE

Aug 07, 02:27 PM

BSE+NSE Vol: 29.16 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
873.25
756.56
807.45
792.41
773.00
705.30
727.45
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
873.25
756.56
807.45
792.41
773.00
705.30
727.45
Raw Material Cost
94.27
68.12
105.85
82.58
70.10
68.28
69.43
Purchase of Finished goods
131.12
122.97
117.24
146.09
104.26
95.98
133.22
(Increase) / Decrease In Stocks
13.86
-5.84
0.21
-26.26
10.28
5.99
-25.77
Employee Cost
153.42
136.85
138.08
137.45
144.43
121.45
125.39
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
184.36
160.89
164.46
164.34
167.22
161.21
174.87
Total Expenditure (Excl Depreciation)
577.03
482.99
525.84
504.20
496.29
452.91
477.14
Operating Profit (PBDIT) excl Other Income
296.22
273.57
281.61
288.21
276.71
252.39
250.31
Other Income
2.39
2.23
0.02
2.81
2.69
7.95
4.22
Operating Profit (PBDIT)
298.61
275.80
281.63
291.02
279.40
260.34
254.53
Interest
46.65
45.62
48.82
49.55
48.68
54.28
57.17
Exceptional Items
0.00
0.00
-17.24
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
251.96
230.18
215.57
241.47
230.72
206.06
197.36
Depreciation
72.07
69.57
70.34
69.08
70.51
77.25
81.00
Profit Before Tax
179.49
159.41
145.35
172.67
161.10
128.87
116.36
Tax
36.17
-119.69
36.52
38.20
36.00
26.52
29.30
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
143.72
280.30
108.71
134.19
124.21
102.29
87.06
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
143.72
280.30
108.71
134.19
124.21
102.29
87.06
Share in Profit of Associates
-0.40
-1.20
0.12
0.28
0.89
0.06
0.00
Minority Interest
0.93
-2.51
9.11
14.28
7.11
8.51
3.30
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
142.39
281.61
99.72
120.19
117.99
93.84
83.76
Equity Capital
13.86
13.85
13.61
13.62
13.62
13.62
13.61
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
3,077.54
0.00
0.00
0.00
Earnings per share (EPS)
10.27
20.33
7.33
8.82
8.66
6.89
6.15
Diluted Earnings per share
10.26
20.57
7.31
8.81
8.64
6.89
6.15
Operating Profit Margin (Excl OI)
34.09%
36.36%
35.16%
36.48%
35.86%
35.92%
34.66%
Gross Profit Margin
28.99%
30.6%
26.92%
30.56%
29.9%
29.33%
27.33%
PAT Margin
16.49%
37.1%
13.59%
17.02%
16.21%
14.57%
12.06%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2026 is 12.97% vs 7.40% in Jun 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2026 is 20.68% vs 41.63% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2026 is 7.05% vs 10.69% in Jun 2025

stock-summary

Interest

YoY Growth in quarter ended Jun 2026 is -4.17% vs -19.36% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025

Compare Quarterly Results Of ERIS Lifescience With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
873.25
600.16
273.09
45.50%
Other Operating Income
0.00
0.00
0.00
Total Operating income
873.25
600.16
273.09
45.50%
Raw Material Cost
94.27
102.11
-7.84
-7.68%
Purchase of Finished goods
131.12
209.02
-77.90
-37.27%
(Increase) / Decrease In Stocks
13.86
-66.13
79.99
120.96%
Employee Cost
153.42
52.62
100.80
191.56%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
184.36
98.30
86.06
87.55%
Total Expenditure (Excl Depreciation)
577.03
395.92
181.11
45.74%
Operating Profit (PBDIT) excl Other Income
296.22
204.24
91.98
45.04%
Other Income
2.39
28.36
-25.97
-91.57%
Operating Profit (PBDIT)
298.61
232.60
66.01
28.38%
Interest
46.65
0.36
46.29
12,858.33%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
251.96
232.24
19.72
8.49%
Depreciation
72.07
18.80
53.27
283.35%
Profit Before Tax
179.49
213.44
-33.95
-15.91%
Tax
36.17
40.56
-4.39
-10.82%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
143.72
172.88
-29.16
-16.87%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
143.72
172.88
-29.16
-16.87%
Share in Profit of Associates
-0.40
0.00
-0.40
Minority Interest
0.93
2.77
-1.84
-66.43%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
142.39
170.11
-27.72
-16.30%
Equity Capital
13.86
15.20
-1.34
-8.82%
Face Value
1.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
10.27
22.38
-12.11
-54.11%
Diluted Earnings per share
10.26
22.31
-12.05
-54.01%
Operating Profit Margin (Excl OI)
34.09%
34.03%
0.00
0.06%
Gross Profit Margin
28.99%
38.70%
0.00
-9.71%
PAT Margin
16.49%
28.81%
0.00
-12.32%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 873.25 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is 15.42% vs -6.30% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 12.97% vs 7.40% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 142.39 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is -49.44% vs 182.40% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 20.68% vs 41.63% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 296.22 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is 8.28% vs -2.86% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 7.05% vs 10.69% in Jun 2025

Quarterly - Interest
Interest 46.65 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is 2.26% vs -6.55% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -4.17% vs -19.36% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 34.09%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025